Monitoring inactive hepatitis B patients is cost-effective strategy
Wednesday, January 15, 2014 - 16:31
in Health & Medicine
A novel study determined that monitoring inactive chronic hepatitis B (HBV) carriers is a cost-effective strategy for China. However, results show that increasing treatment, monitoring and adherence to therapy are necessary to achieve significant health benefits at the population level.